Allergy and Asthma Proceedings

Papers
(The median citation count of Allergy and Asthma Proceedings is 3. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-01-01 to 2026-01-01.)
ArticleCitations
Impact of steroids on the immune profiles of children with asthma living in the inner-city81
Long-COVID and loss of smell: A post-COVID olfactory dysfunction that continues to challenge the allergist/immunologist45
Pearls and pitfalls: Adverse cutaneous reactions after COVID-19 vaccination39
Molecular allergy diagnostics in predicting oral cow's milk challenge outcome in Finnish children29
The role of leukocyte activation in suspected Non-IgE excipient-related COVID-19 vaccine reactions: An exploratory hypothesis-driven study of pathogenesis29
Real-world reporting rates of administration-site reactions with on-demand treatment of hereditary angioedema attacks26
Hereditary Angioedema: Impact of COVID-19 pandemic stress upon disease related morbidity and well-being22
Future directions in allergen immunotherapy21
Venom allergen immunotherapy20
Association of exposure to ambient particulate matter with asthma in children: Systematic review and meta-analysis20
Operationalizing shared decision making in clinical practice19
Clinical remission in patients with severe eosinophilic asthma treated with mepolizumab: A post-hoc analysis of RELIght study18
Demographics and characteristics of leadership at allergy and immunology fellowships in the U.S. as of 202217
Abstracts presented at the Western Society of Allergy, Asthma & Immunology, Annual Scientific Session, February 6-10, 2022, Maui, Hawaii16
For the Patient15
Evaluation and management of chronic cough in adults15
For the Patient15
For the Patient15
Body weight trajectory of non-obese asthmatics: Relationship with inhaled corticosteroids maintenance therapy13
Clinical effects of intranasal corticosteroids on nasal symptoms in subjects with chronic rhinitis during COVID-1913
Quality of life in primary immunodeficiency: Its contribution to shared decision-making and patient outcomes13
Assessment of pediatric patients with suspected nonsteroidal anti-inflammatory drug hypersensitivity13
The safety of initial single therapeutic dose challenge with a 5-day prolonged drug provocation test in children with a history of low-risk non-immediate reactions to beta-lactam antibiotics12
Comparison of commercial allergen extract with various milk products of skin prick tests in diagnosing cow's milk protein allergy12
Systematic review of omalizumab for refractory clonal and non-clonal mast cell activation syndrome12
Epinephrine autoinjector prescribing following anaphylaxis presentation to the emergency department12
TEV/FEV3 as a coherent metric of small airway dysfunction in childhood asthma12
Association between air pollution and the prevalence of allergic rhinitis in Chinese children: A systematic review and meta-analysis12
Positive perception of COVID-19 vaccination in HAE: No significant impact of vaccination on disease course12
The burden of systemic corticosteroids in patients with chronic rhinosinusitis with nasal polyps12
For the Patient11
For the Patient11
Can depression and anxiety be predicted in hereditary angioedema? A comprehensive assessment11
Unraveling allergic, pseudoallergic, and idiosyncratic complexities of hypersensitivity reactions to NSAIDs11
Is it time for the A/I (allergist/immunologist) to embrace AI (artificial intelligence) in diagnosis and treatment of the inborn errors of immunity?11
Treatment strategies for postviral olfactory dysfunction: A systematic review11
Diagnostic utility of basophil CD203c expression in β-lactam allergy11
Artificial intelligence and allergy: Shaping the future of diagnosis and therapy11
Navigating the management complexity in long-term asymptomatic immunodeficiency10
Abstracts Presented at the Western Society of Allergy, Asthma & Immunology, February 4‐8, 2024, Koloa, Hawaii10
Eosinophilic granulomatosis with polyangiitis in allergic asthma: Efforts to make early diagnosis possible10
From burden to breakthrough: Advances in hereditary angioedema, drug allergy, and allergic disease prevention10
Oral food challenge to milk is still necessary to diagnose cow's milk allergy and should be conducted in adequate facilities10
For the patient10
Guidelines for management of hereditary angioedema: What is new? What is missing?10
Effects of mechanical washing and drying on the removal of pet allergens10
A tribute to allergy and immunology fellowship training program directors and to the fellows they train10
A case of a rash after tetanus-diphtheria-pertussis and meningococcal vaccination10
Long-term efficacy of the sublingual and subcutaneous routes in allergen immunotherapy10
Real-world effectiveness of dupilumab versus benralizumab and mepolizumab9
Shared decision-making in the management of hereditary angioedema: An analysis of patient and physician perspectives9
Hematopoietic stem cell transplantation for primary immunodeficiency9
Metal implant allergy: A retrospective cohort analysis at a university allergy practice9
Evaluation of atopic diseases in patients with allergic contact dermatitis9
Benralizumab in the management of rare primary eosinophilic lung diseases9
Presented at the Western Society of Allergy, Asthma & Immunology, February 5‐9, 2023, Kamuela, Hawaii9
The long COVID syndrome: A conundrum for the allergist/immunologist9
Clinical features of anaphylaxis in children8
Prophylactic therapy with subcutaneous C1-inhibitor is associated with sustained symptom control in patients with hereditary angioedema8
Chronic spontaneous urticaria after BNT162b2 mRNA (Pfizer-BioNTech) vaccination against SARS-CoV-28
Proton-pump inhibitors are associated with an increased risk of asthma: A nationwide nested case-control study8
Primary Immunodeficiency: Specific antibody deficiency with normal IgG8
The association of timothy grass allergy and cat ownership on cat sensitization8
Birch-naive, oak-allergic subjects' response to birch pollen in an environmental chamber8
Cost-effectiveness of school integrated pest management and air filtration in students with asthma8
Overview of secondary immunodeficiency8
Penicillin allergy labels are associated with a greater number of courses of antibiotics after hospitalization8
Adding tiotropium or long-acting β2-agonists to inhaled corticosteroids: Asthma-related exacerbation risk and healthcare resource utilization8
Delayed pressure urticaria successfully treated with omalizumab: A tertiary-level health-care center experience7
Early clinical improvement of anosmia and sinus nitric oxide in chronic rhinosinusitis with nasal polyps subjects treated with dupilumab7
Impact of penicillin allergy labels among pneumonia admissions at an academic children's center7
Curcumin does not significantly affect immediate skin tests7
Real-world effectiveness and predictors of super-responders to dupilumab in a Chinese uncontrolled asthma cohort7
Abstracts published from the New England Society of Allergy Annual Fall Meeting, October 22‐23, 2022, Portsmouth, NH7
Markers of eosinophilic airway inflammation in patients with asthma and allergic rhinitis7
2-Octyl cyanoacrylate, a hidden allergen, a common cause of postsurgical allergic contact dermatitis7
Quality of life and burden of disease in patients with hereditary angioedema and their caregivers7
For the Patient7
Efficacy of anti-interleukin 5 therapy in hypereosinophilic syndrome: An updated systematic review and meta-analysis7
Real-world surveillance of standardized quality (SQ) house dust mite sublingual immunotherapy tablets for 3 years in Japan7
Initial updosing phase of oral immunotherapy improves quality of life and psychological burden in parents of children with food allergy6
For the patient6
Peanut allergy in an adult following cardiac transplant from a non-atopic donor6
Efficacy of parenteral bronchodilators on ventilatory outcomes in pediatric critical asthma: a national cohort study6
Immunodeficiency: Burden of Illness6
Assessing cross-reactivity in allergen immunotherapy6
Predictive factors of recurrence after omalizumab cessation in the elderly with urticaria: A real-life study6
Essentials of an immunodeficiency primer: A practical reference for the allergist/immunologist and the allergy-immunology fellow-in-training (FIT)6
Clinical and economic burden of chronic rhinosinusitis with nasal polyposis: A U.S. administrative claims analysis6
Evaluation of allergic diseases in children diagnosed with cutaneous mastocytosis6
The long-term outcomes of mepolizumab treatment at 100 mg dose on idiopathic chronic eosinophilic pneumonia: A real-life experience6
A masquerade of recurrent anaphylaxis6
Delayed systemic urticarial reactions following mRNA COVID-19 vaccination6
Abstracts presented at the Eastern Allergy Conference, June 3‐6, 2021, Palm Beach, Florida6
Multicenter questionnaire study investigating characteristics of adults with unexplained chronic cough versus explained chronic cough6
Diagnosis of eosinophilic esophagitis in patients with dysphagia during the Coronavirus Disease 2019 (COVID-19) pandemic6
Impact of perinatal risk factors on pediatric asthma: A systematic review and meta-analysis5
Early testing and grade of the reaction are affecting factors of skin test positivity in β-Lactam allergies5
The COVID-19 impact on severe uncontrolled asthma costs and biologic use5
A review of allergen immunotherapy in asthma5
Studies of methylated CpG ODN from Bifidobacterium longum subsp. infantis in a murine model: Implications for treatment of human allergic disease5
Blended problem based learning in postgraduate education: The Eastern Allergy Conference and the PBL Institute experience5
Long-term omalizumab treatment outcomes in patients with allergic bronchopulmonary aspergillosis5
Genetically-determined defects of T cell development5
Real-world surveillance of standardized quality (SQ) house dust mite sublingual immunotherapy tablets for 3 years in Japan5
A confluence of advanced treatment options for atopic dermatitis, eosinophilic lung diseases and chronic urticaria brought about by the revolutionary discovery of biologics and Janus kinase inhibitors5
Treatment options for moderate to severe atopic dermatitis5
A comparative study of chronic spontaneous urticaria and chronic mast cell mediated angioedema5
Mechanisms and biomarkers of subcutaneous immunotherapy and sublingual immunotherapy in allergen immunotherapy5
Influence of aeroallergen sensitization and nasal polyposis on mepolizumab response in eosinophilic severe asthma5
Efficacy and safety of Janus kinase selective inhibitors in the treatment of atopic dermatitis: A systematic review and meta-analysis5
Expanding horizons of omalizumab: New frontiers in asthma and beyond5
Anaphylaxis: Long-term management and resources5
Successful rapid liposomal amphotericin B desensitization in pediatric case series5
Cat allergy in children and the effect of the COVID-19 pandemic5
Abstracts presented at the Eastern Allergy Conference, June 2‐5, 2022, Palm Beach, Florida5
Interleukin-33, endothelin-1, and inflammatory parameters in chronic spontaneous urticaria5
Evaluation of disease control after SARS-CoV-2 infection or vaccination in patients with NSAID-exacerbated airway disease5
Clinical implications of asthma endotypes and phenotypes4
Salivary and serum IgA and IgG after COVID-19 and after immunization with COVID-19 vaccines4
Atopic dermatitis: Best of guidelines and yardstick4
A systematic review and meta-analysis exploring the bidirectional association between asthma and gastroesophageal reflux disease in children4
Current concepts in optimized construction of allergen immunotherapy vaccines: Practical implications4
Comparative analysis of demographic and clinical features in common variable immunodeficiency and selective immunoglobulin G deficiency4
Allergy immunotherapy for allergic fungal respiratory diseases4
Evaluation of direct oral provocation test results in mild cutaneous reactions to cephalosporins in children4
Removing penicillin allergy label in a hospitalized adolescent with a remote penicillin and recent cephalosporin allergy4
For the patient4
Clinical predictors of breakthrough reactions during initial rapid drug desensitizations to platinum chemotherapeutics4
Factors influencing the quality of life in children with atopic dermatitis in Korea: A multicenter cross-sectional study4
Dose-dependent association between inhaled corticosteroid use and risk of obesity and metabolic syndrome in asthma4
The diagnostic accuracy of spirometry versus peak expiratory flow test for follow-up of adult asthma patients at primary care level4
Addressing global health disparities in the management of RSV infection in infants and children: Strategies for preventing bronchiolitis and post-bronchiolitis recurrent wheezing4
Prevalence and bidirectional association between rhinitis and urticaria: A systematic review and meta-analysis4
The complexities of allergic diseases continue to challenge the allergist-immunologist4
Exploring mast cell disorders: Tryptases, hereditary alpha-tryptasemia, and MCAS treatment approaches4
Selective immunoglobulin E deficiency and its association with autoimmune and autoinflammatory diseases4
Aeroallergen immunotherapy update: Developments since the third Practice Parameter4
The lymphocyte-eosinophil to neutrophil-monocyte ratio as a potential composite biomarker associated with asthma exacerbations in adults4
Peptide immunotherapy for aeroallergens4
Initial characteristics and follow-up of patients with a diagnosis of angiotensin-converting enzyme inhibitor induced angioedema4
Integrating innovation and shared decision-making in allergy and immunology practice4
Management and referral patterns for new-onset chronic cough in primary care patients4
Health disparities investigated in a primary care penicillin allergy removal pathway4
Common but neglected problem in chronic spontaneous urticaria: Sleep disturbance4
The utility of shared decision making in the management of hereditary angioedema4
Assessment of mask use on oxygen saturation in adults and children with asthma4
In-vivo allergen extract potency is maintained in a sublingual immunotherapy maintenance vial of pollens and mites4
Specific immunoglobulin E for aeroallergens: 0.35 kUA/L cutoff value is too low4
Interaction between asthma and overweight/obesity on cancer results from the National Health and Nutrition Examination Survey 2005‐20183
Capturing total steroid burden in patients with atopic dermatitis and asthma3
Evaluation of different protocols for classification of pediatric hypersensitivity reactions to nonsteroidal anti-inflammatory drugs: Children with underlying allergic disease should be a separate sub3
Angioedema without urticaria: Diagnosis and management3
Eosinophil-derived neurotoxin: An asthma exacerbation biomarker in children3
The challenge of neurologic disease for the allergist/immunologist3
Early-life risk factors for recurrent wheezing in preschool children: A meta-analysis of 15 cohort studies3
Caregiver perceptions of β-lactam allergy testing for serum sickness-like reactions3
Oral immunotherapy with sunflower seed butter and a review of seed allergy3
Subcutaneous allergen immunotherapy in the treatment of allergic respiratory disease3
Allergic comorbidities in fibromyalgia3
For the patient3
Hymenoptera venom immunotherapy: Safety and efficacy of an accelerated induction regimen with depot aluminum adsorbed extracts3
Single-bag rapid drug desensitization for chemotherapeutic hypersensitivity reactions: A single-center experience3
Pediatric sublingual allergen immunotherapy3
From diagnosis to desensitization in immediate hypersensitivity reactions to both oral and parenteral iron salts3
Appraisal of the evidence linking hereditary α-tryptasemia with mast cell disorders, hypermobility and dysautonomia3
Fruit allergy and anaphylaxis in children: Culprit fruits and clinical findings3
Dose-response studies of methylated and nonmethylated CpG ODNs from Bifidobacterium longum subsp. infantis for optimizing Treg cell stimulation3
Chronic cough in asthma is associated with increased airway inflammation, more comorbidities, and worse clinical outcomes3
The effect of the socioeconomic status on the measurement of asthma control3
Diagnosis of ciprofloxacin hypersensitivity improves by incorporating MRGPRX2 in basophil activation test3
Monitored COVID-19 mRNA vaccine second doses for people with adverse reactions after the first dose3
Becoming attack-free further improves health-related quality of life in patients with hereditary angioedema receiving garadacimab3
Relationship between autoimmune diseases and serum basal immunoglobulin E levels in patients with common variable immunodeficiency3
Impact of nasal congestion on intranasal rescue medication absorption and efficacy: A systematic review3
Prognosis of food-induced anaphylaxis in children: A single-center real-life study3
Evaluation of sinonasal involvement in patients with asthma and chronic obstructive pulmonary disease3
Managing food allergies in each stage of life3
United States Pharmacopeia guidance for compounding of allergenic extracts for allergen immunotherapy3
SNOT-22 scores after 6 months of aspirin therapy are predictive of long-term quality of life in AERD3
Impact of baseline body mass index on asthma incidence in middle-aged and elderly populations: A prospective analysis from China3
The third pandemic: The respiratory syncytial virus landscape and specific considerations for the allergist/immunologist3
Accelerated/rush allergen immunotherapy3
0.42003893852234